loader
Please Wait
Applying Filters...

Evonik Evonik

X

List of Drug Master Files (KDMF) for Ninlaro Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Korea.

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Ash Stevens LLC (1)

filter

01 Takeda Pharmaceutical Korea Co., Ltd. (1)

filter

01 Ixazomib Citrate (1)

filter

01 U.S.A (1)

URL Supplier Web Content
Takeda Pharmaceutical Korea Co., Ltd.
2019-01-29
20190308-211-J-316
Ash Stevens LLC
U.S.A
18655 Krause St. Rivervie...
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 1239908-20-3 / Ixazomib Citrate API manufacturers, exporters & distributors?

Ixazomib Citrate manufacturers, exporters & distributors 1

41

PharmaCompass offers a list of Ixazomib Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ixazomib Citrate manufacturer or Ixazomib Citrate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ixazomib Citrate manufacturer or Ixazomib Citrate supplier.

PharmaCompass also assists you with knowing the Ixazomib Citrate API Price utilized in the formulation of products. Ixazomib Citrate API Price is not always fixed or binding as the Ixazomib Citrate Price is obtained through a variety of data sources. The Ixazomib Citrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Ixazomib Citrate

Synonyms

1239908-20-3, Ixazomib citrate (ester), Ixazomib citrate [usan], 46cwk97z3k, 2-[4-(carboxymethyl)-2-[(1r)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4-yl]acetic acid, Unii-46cwk97z3k

Cas Number

1239908-20-3

Unique Ingredient Identifier (UNII)

46CWK97Z3K

About Ixazomib Citrate

Ixazomib Citrate is the citrate salt form of ixazomib, an orally bioavailable second generation proteasome inhibitor (PI) with potential antineoplastic activity. Ixazomib inhibits the activity of the proteasome, blocking the targeted proteolysis normally performed by the proteasome, which results in an accumulation of unwanted or misfolded proteins; disruption of various cell signaling pathways may follow, resulting in the induction of apoptosis. Compared to first generation PIs, second generation PIs may have an improved pharmacokinetic profile with increased potency and less toxicity. Proteasomes are large protease complexes that degrade unneeded or damaged proteins that have been ubiquinated.

Ninlaro Manufacturers

A Ninlaro manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ninlaro, including repackagers and relabelers. The FDA regulates Ninlaro manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ninlaro API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Ninlaro manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Ninlaro Suppliers

A Ninlaro supplier is an individual or a company that provides Ninlaro active pharmaceutical ingredient (API) or Ninlaro finished formulations upon request. The Ninlaro suppliers may include Ninlaro API manufacturers, exporters, distributors and traders.

click here to find a list of Ninlaro suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Ninlaro KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Ninlaro Drug Master File in Korea (Ninlaro KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ninlaro. The MFDS reviews the Ninlaro KDMF as part of the drug registration process and uses the information provided in the Ninlaro KDMF to evaluate the safety and efficacy of the drug.

After submitting a Ninlaro KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ninlaro API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Ninlaro suppliers with KDMF on PharmaCompass.

Ninlaro Manufacturers | Traders | Suppliers

Ninlaro Manufacturers, Traders, Suppliers 1
66

We have 1 companies offering Ninlaro

Get in contact with the supplier of your choice:

  1. Ash Stevens, Inc.
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY